Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsJay Short - Co-Founder, CEO & ChairmanSheri Lydick - ...
2don MSN
BioAtla outlines $800M peak sales target for Oz-V as FDA alignment paves way for phase III launch
Q3 2025 Management View Jay Short, Co-Founder, CEO & Chairman, emphasized that BioAtla is "currently in advanced stages to ...
Earlier this afternoon, BioAtla, Inc. released financial results and a business update for the quarter ended 09/30/2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback